Skip to main content
. 2019 Mar 11;44(10):1812–1819. doi: 10.1038/s41386-019-0365-0

Fig. 2.

Fig. 2

Change in MADRS score during clinical trial of lithium/placebo continuation therapy following ketamine in patients with treatment-resistant depression (n = 34). Values reflect means with associated 95% CI. Only upper or lower bounds are shown for clarity. MADRS, Montgomery–Åsberg Depression Rating Scale